SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease

Antonio Tursi^{1

2}, Loris Riccardo Lopetuso^{3

4

5}, Lorenzo Maria Vetrone⁵, Antonio Gasbarrini^{5

6}, Alfredo Papa^{5

6}

Affiliations

¹ Territorial Gastroenterology Service, ASL BAT, Andria.
² Department of Medicine and Surgery, Post-Graduate School of Digestive Disease, Catholic University, Rome.
³ Department of Medicine and Ageing Sciences, "G. d'Annunzio" University of Chieti- Pescara.
⁴ Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti.
⁵ CEMAD, Digestive Disease Center, Fondazione Policlinico A. Gemelli, IRCCS.
⁶ Department of Medicine and Surgery, Catholic University, Rome, Italy.

Antonio Tursi et al. Eur J Gastroenterol Hepatol. 2022.

. 2022 Aug 1;34(8):883-884.

doi: 10.1097/MEG.0000000000002379. Epub 2022 Jun 29.

Antonio Tursi^{1

2}, Loris Riccardo Lopetuso^{3

4

5}, Lorenzo Maria Vetrone⁵, Antonio Gasbarrini^{5

6}, Alfredo Papa^{5

6}

¹ Territorial Gastroenterology Service, ASL BAT, Andria.
² Department of Medicine and Surgery, Post-Graduate School of Digestive Disease, Catholic University, Rome.
³ Department of Medicine and Ageing Sciences, "G. d'Annunzio" University of Chieti- Pescara.
⁴ Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti.
⁵ CEMAD, Digestive Disease Center, Fondazione Policlinico A. Gemelli, IRCCS.
⁶ Department of Medicine and Surgery, Catholic University, Rome, Italy.

No abstract available

References

1. Papa A, Gasbarrini A, Tursi A. Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2020;115:1722–1724. - PMC - PubMed
1. Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008;135:781–786. - PubMed
1. Calabrese E, Zorzi F, Monteleone G, Del Vecchio Blanco G. Onset of ulcerative colitis during SARS-CoV-2 infection. Dig Liver Dis. 2020;52:1228–1229. - PMC - PubMed
1. Taxonera C, Fisac J, Alba C. Can COVID-19 Trigger De Novo Inflammatory Bowel Disease? Gastroenterology. 2021;160:1029–1030. - PMC - PubMed
1. Imperatore N, Bennato R, D’Avino A, Lombardi G, Manguso F. SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis. Inflamm Bowel Dis. 2021;27:e87–e88. - PMC - PubMed